A Phase III Double-blind Randomised Study Assessing the Efficacy and
Safety of Capivasertib + Paclitaxel Versus Placebo + Paclitaxel as First-line
Treatment for Patients with Histologically Confirmed, Locally Advanced
Inoperable or Metastatic Triple-Negative Breast Cancer TNBC
A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High Risk Retroperitoneal Sarcoma STRASS2
Disparities in REsults of Immune Checkpoint Inhibitor Treatment DiRECT:
A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting
First-in-Human Phase I Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Metarrestin ML-246 in Subjects with Metastatic Solid Tumors
StepByStep: A Randomized Trial of a Mobile Health and Social Media Physical Activity Intervention among Adolescent and Young Adult Childhood Cancer Survivors
Phase IIIB, MulitCenter, Single-Arm, Open-Label Efficacy and Safety Study of Fedratinib in Subject DIPSS-I or High- Risk Primary Myelofibrosis, Post- Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis and Previously Treated with Ruxolitinib Including a Sub-study with Concomitant Luspatercept for Subjects with Anemia The ?FREEDOM? trial